Thailand says on track to use Sinovac vaccine, despite trial data
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
FRIDAY, MAY 20, 2022
FRIDAY, MAY 20, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Thailand says on track to use Sinovac vaccine, despite trial data

Coronavirus chronicle

Reuters
13 January, 2021, 04:25 pm
Last modified: 13 January, 2021, 04:26 pm

Related News

  • Tourist favourite Thailand's recovery lags on Covid rule changes
  • Thai govt says Ramadan bombings won't derail peace talks with rebels
  • Covid to crypto-amulets: Young Thais seek fortune-telling upgrades
  • Despite risk of death, Thailand sends Myanmar refugees back
  • Thailand bids to avert 'population crisis' as birth rate crashes

Thailand says on track to use Sinovac vaccine, despite trial data

"There is no impact on our plan right now," Supakit Sirilak, Director-General of Medical Science Department, told a briefing when asked about Brazil's data

Reuters
13 January, 2021, 04:25 pm
Last modified: 13 January, 2021, 04:26 pm
A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (Covid-19) vaccine, during a government-organized media tour in Beijing, China, 24 September, 2020/Reuters
A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (Covid-19) vaccine, during a government-organized media tour in Beijing, China, 24 September, 2020/Reuters

Thailand on Wednesday said it was still on track to receive and administer a coronavirus vaccine by China's Sinovac Biotech starting next month, despite data from a Brazil trial that showed 50.4% efficiency, health officials said.

"There is no impact on our plan right now," Supakit Sirilak, Director-General of Medical Science Department, told a briefing when asked about Brazil's data.

"We are asking for information directly from Sinovac, so we are waiting for their response to get all the facts," he said.

Thailand, which has reported a total of 10,991 infections and 67 fatalities since it detected its first case a year ago, has ordered 2 million doses of Sinovac's CoronaVac and expects to receive the first 200,000 doses next month.

It has also ordered 61 million doses of the AstraZeneca vaccine, which will be produced by local firm, Siam Bioscience for domestic use and export.

The Brazil trial findings came just as Indonesia started a massive coronavirus vaccination campaigns, with its president the first to be inoculated with CoronaVac

Malaysia on Wednesday said it would only go ahead with procurement of Sinovac's vaccine if it satisfies the safety and efficacy standards of local regulators.

Thailand's Food and Drug Administration on Wednesday said it was assessing all vaccines based on quality, safety and efficiency.

"The companies requesting approval must provide information that addresses all these points," FDA Deputy Secretary-General Surachoke Tangwiwat said.

Thailand received requests on Tuesday for vaccine registration from AstraZeneca and Sinovac. 

thailand / Sinovac Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • US growth seen outpacing China’s for first time since 1976
    US growth seen outpacing China’s for first time since 1976
  • BNP misinterpreting PM's comment over Padma Bridge: Quader
    BNP misinterpreting PM's comment over Padma Bridge: Quader
  • Students suffer over costlier food at public university canteens
    Students suffer over costlier food at public university canteens

MOST VIEWED

  • Ryu Yong Chol, an official at North Korea's state emergency epidemic prevention headquarters, speaks during a daily coronavirus program on state-run television KRT, in this still image obtained from KRT footage released on May 20, 2022. REUTERS TV/KRT via REUTERS
    North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Shanghai detects new infections after five days of 'zero Covid'
  • Volunteers carry out temperature screening during an anti-virus campaign in Pyongyang, North Korea in this image released by North Korea's Korean Central News Agency (KCNA) on March 4, 2020. KCNA via REUTERS/File Photo
    North Korea hails 'good results' on Covid as fever cases pass 2 million
  • Medical staff members check the temperature of people as they enter at Capital Airport, following an outbreak of Covid-19, in Beijing, China, 5 November, 2020. Photo: Reuters
    China relaxes some Covid test rules for US, other travellers
  • Representational image.
    China Junshi's potential Covid drug shows promise in small trial
  • A woman wearing protective mask walks at a sidewalk near business district in Jakarta, Indonesia March 2, 2020. REUTERS/Willy Kurniawan/Files
    Indonesia to drop outdoor mask mandate as Covid-19 infections drop

Related News

  • Tourist favourite Thailand's recovery lags on Covid rule changes
  • Thai govt says Ramadan bombings won't derail peace talks with rebels
  • Covid to crypto-amulets: Young Thais seek fortune-telling upgrades
  • Despite risk of death, Thailand sends Myanmar refugees back
  • Thailand bids to avert 'population crisis' as birth rate crashes

Features

Mohammad (Mejbah) Mejbahuddin, Former Senior Secretary, Economic Relations Division (ERD), Ministry of Finance, Government of Bangladesh. TBS Sketch

‘No project is being delayed too long at the moment’

5h | Panorama
Dr Shamsul Hoque, Professor, Civil Engineering, BUET. TBS Sketch

‘Planning commission only in the name, there are no planners’ 

5h | Panorama
Masrur Reaz. TBS Sketch

‘To ensure accountability, contract financing should be based on ‘performance based payments’

5h | Panorama
Professor Mustafizur Rahman. Illustration: TBS

Project delays and escalating costs are driven by frequent revisions and lack of good governance

8h | Panorama

More Videos from TBS

Ways to retain body fragrance

Ways to retain body fragrance

6h | Videos
Gazipur restaurant that serves 150 food items

Gazipur restaurant that serves 150 food items

10h | Videos
How to prepare for a job

How to prepare for a job

11h | Videos
Putin's strategies to face Nato

Putin's strategies to face Nato

23h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

3
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

4
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

5
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

6
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab